Antioxidant therapy for atherosclerotic vascular disease: The promise and the pitfalls

Ahmad Shihabi, Wei Gen Li, Francis J. Miller, Neal Lee Weintraub

Research output: Contribution to journalEditorial

32 Citations (Scopus)
Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume282
Issue number3 51-3
StatePublished - Jun 29 2002

Fingerprint

Arteriosclerosis
Vascular Diseases
LDL Lipoproteins
Superoxides
Nitric Oxide
Antioxidants
Therapeutics

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Antioxidant therapy for atherosclerotic vascular disease : The promise and the pitfalls. / Shihabi, Ahmad; Li, Wei Gen; Miller, Francis J.; Weintraub, Neal Lee.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 282, No. 3 51-3, 29.06.2002.

Research output: Contribution to journalEditorial

@article{5752bd4a2b8e4d00921cf6bb1be7ede9,
title = "Antioxidant therapy for atherosclerotic vascular disease: The promise and the pitfalls",
author = "Ahmad Shihabi and Li, {Wei Gen} and Miller, {Francis J.} and Weintraub, {Neal Lee}",
year = "2002",
month = "6",
day = "29",
language = "English (US)",
volume = "282",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3 51-3",

}

TY - JOUR

T1 - Antioxidant therapy for atherosclerotic vascular disease

T2 - The promise and the pitfalls

AU - Shihabi, Ahmad

AU - Li, Wei Gen

AU - Miller, Francis J.

AU - Weintraub, Neal Lee

PY - 2002/6/29

Y1 - 2002/6/29

UR - http://www.scopus.com/inward/record.url?scp=0036088007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036088007&partnerID=8YFLogxK

M3 - Editorial

C2 - 11834471

AN - SCOPUS:0036088007

VL - 282

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 3 51-3

ER -